.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Accenture
AstraZeneca
Deloitte
US Army
Argus Health
McKesson
Fuji
Cerilliant
Dow

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088481

« Back to Dashboard
NDA 088481 describes DEXAMETHASONE, which is a drug marketed by ECR, Phoenix Labs Ny, West-ward Pharms Int, Sun Pharm Inds, Roxane, Watson Labs, Pvt Form, Whiteworth Town Plsn, Upsher Smith, Xspire Pharma, Par Pharm, Abraxis Pharm, Sti Pharma Llc, Wockhardt Eu Operatn, Fresenius Kabi Usa, Larken Labs Inc, Impax Labs, Vintage Pharms, Lyne, Alpharma Us Pharms, Idt Australia Ltd, Watson Labs Teva, Mylan Labs Ltd, Intl Medication, Teva Parenteral, Luitpold, Wyeth Ayerst, Bel Mar, Akorn, Dell Labs, Lyphomed, Bausch And Lomb, Sola Barnes Hind, Sandoz Inc, and Aurobindo Pharma Ltd, and is included in seventy-eight NDAs. It is available from thirty-three suppliers. Additional details are available on the DEXAMETHASONE profile page.

The generic ingredient in DEXAMETHASONE is dexamethasone acetate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone acetate profile page.

Summary for NDA: 088481

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 088481

Mechanism of ActionCorticosteroid Hormone Receptor Agonists

Suppliers and Packaging for NDA: 088481

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXAMETHASONE
dexamethasone
 TABLET;ORAL 088481 ANDA Par Pharmaceutical Inc. 49884-373 49884-373-01 100 TABLET in 1 BOTTLE, PLASTIC (49884-373-01)
DEXAMETHASONE
dexamethasone
 TABLET;ORAL 088481 ANDA Integrated Pharma Solutions Llc 61219-996 61219-996-21 1 KIT in 1 CARTON (61219-996-21) * 2 TABLET in 1 BOTTLE, PLASTIC (61219-084-02) * 3 mL in 1 PACKET (61219-374-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength6MG
Approval Date:Nov 28, 1983TE:BPRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Covington
Daiichi Sankyo
Dow
Merck
QuintilesIMS
AstraZeneca
McKesson
Federal Trade Commission
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot